SARS-CoV-2: What do we know so far?
作者信息
Khedkar Pratik H, Patzak Andreas
机构信息
Institut für Vegetative Physiologie, Charité - Universitätsmedizin Berlin, corporate member of the Freie Universität Berlin, Humboldt Universität zu Berlin and the Berlin Institute of Health, Berlin, Germany.
出版信息
Acta Physiol (Oxf). 2020 Jun;229(2):e13470. doi: 10.1111/apha.13470. Epub 2020 Apr 11.
Abstract
摘要
相似文献
1
SARS-CoV-2: What do we know so far?新型冠状病毒（SARS-CoV-2）：我们目前了解到了什么？
Acta Physiol (Oxf). 2020 Jun;229(2):e13470. doi: 10.1111/apha.13470. Epub 2020 Apr 11.
2
China Coronavirus Outbreak: All the Latest Updates.中国新冠疫情：所有最新消息。
Curr Top Med Chem. 2020;20(8):601-602. doi: 10.2174/1568026620999200305144537.
3
Risk factors for viral RNA shedding in COVID-19 patients.COVID-19 患者病毒 RNA 脱落的风险因素。
Eur Respir J. 2020 Jul 2;56(1). doi: 10.1183/13993003.01190-2020. Print 2020 Jul.
4
COVID-19 and Lessons to Be Learned from Prior Coronavirus Outbreaks.新型冠状病毒肺炎以及从既往冠状病毒爆发中吸取的教训。
Ann Am Thorac Soc. 2020 Jul;17(7):790-794. doi: 10.1513/AnnalsATS.202002-149PS.
5
The Wuhan SARS-CoV-2-What's next for China.武汉的新冠病毒——中国的下一步是什么。
J Med Virol. 2020 Jun;92(6):546-547. doi: 10.1002/jmv.25738. Epub 2020 Mar 18.
6
A Call for a Three-Tiered Pandemic Public Health Strategy in Context of SARS-CoV-2.呼吁在新冠病毒背景下制定三级大流行公共卫生战略。
Rejuvenation Res. 2020 Aug;23(4):281-283. doi: 10.1089/rej.2020.2363. Epub 2020 Jun 24.
7
Molecular structure analyses suggest strategies to therapeutically target SARS-CoV-2.分子结构分析提示了针对 SARS-CoV-2 的治疗靶点策略。
Nat Commun. 2020 Jun 10;11(1):2920. doi: 10.1038/s41467-020-16779-4.
8
COVID-19 and the Forgotten Majority.新冠疫情与被遗忘的大多数
High Blood Press Cardiovasc Prev. 2020 Oct;27(5):339. doi: 10.1007/s40292-020-00407-9. Epub 2020 Aug 29.
9
Genetic characterization of SARS-CoV-2 & implications for epidemiology, diagnostics & vaccines in India.新型冠状病毒（SARS-CoV-2）的基因特征及其对印度流行病学、诊断和疫苗的影响。
Indian J Med Res. 2020;152(1 & 2):12-15. doi: 10.4103/ijmr.IJMR_3667_20.
10
Protect against market exclusivity in the fight against COVID-19.在抗击新冠疫情中防范市场独占。
Nat Med. 2020 Jun;26(6):813. doi: 10.1038/s41591-020-0876-6.
引用本文的文献
1
Health Literacy of the Inland Population in Mitigation Phase 3.2 of the COVID-19 Pandemic in Portugal: A Descriptive Cross-Sectional Study.葡萄牙新冠疫情缓解阶段3.2中内陆人口的健康素养：一项描述性横断面研究
Port J Public Health. 2020 Dec 14;38(2):1-11. doi: 10.1159/000511216.
2
Systematic Review on Pathophysiological Complications in Severe COVID-19 among the Non-Vaccinated and Vaccinated Population.未接种疫苗和接种疫苗人群中重症 COVID-19 病理生理并发症的系统评价
Vaccines (Basel). 2022 Jun 21;10(7):985. doi: 10.3390/vaccines10070985.
3
Use of social media for COVID-19-related information and associated factors among health professionals in Northwest Ethiopia: A cross-sectional study.埃塞俄比亚西北部卫生专业人员使用社交媒体获取新冠肺炎相关信息及相关因素：一项横断面研究
Digit Health. 2022 Jul 11;8:20552076221113394. doi: 10.1177/20552076221113394. eCollection 2022 Jan-Dec.
4
Role of imaging in rare COVID-19 vaccine multiorgan complications.影像学在罕见的新冠疫苗多器官并发症中的作用
Insights Imaging. 2022 Mar 14;13(1):44. doi: 10.1186/s13244-022-01176-w.
5
Status of radiotherapy staff during the coronavirus disease 2019 (COVID-19) epidemic in China.2019年冠状病毒病（COVID-19）疫情期间中国放疗工作人员的状况
Precis Radiat Oncol. 2021 Nov 8;5(4):222-225. doi: 10.1002/pro6.1134. eCollection 2021 Dec.
6
A Machine-Generated View of the Role of Blood Glucose Levels in the Severity of COVID-19.机器生成的视角：血糖水平在 COVID-19 严重程度中的作用。
Front Public Health. 2021 Jul 28;9:695139. doi: 10.3389/fpubh.2021.695139. eCollection 2021.
7
Getting it right matters! Covid-19 pandemic analogies to everyday life in medical sciences.做对至关重要！新冠疫情与医学科学中的日常生活类比。
Acta Physiol (Oxf). 2021 Sep;233(1):e13714. doi: 10.1111/apha.13714. Epub 2021 Jul 14.
8
Computational Prediction of Potential Inhibitors of the Main Protease of SARS-CoV-2.新型冠状病毒主要蛋白酶潜在抑制剂的计算预测
Front Chem. 2020 Dec 23;8:590263. doi: 10.3389/fchem.2020.590263. eCollection 2020.
9
A novel hospital capacity versus clinical justification triage score (CCTS) for prioritization of spinal surgeries in the "new normal state" of the COVID-19 pandemic.一种新型的医院容量与临床合理性分诊评分（CCTS），用于在新冠疫情“新常态”下对脊柱手术进行优先级排序。
Eur Spine J. 2021 May;30(5):1247-1260. doi: 10.1007/s00586-020-06679-y. Epub 2021 Jan 2.
10
Tackling SARS-CoV-2: proposed targets and repurposed drugs.应对 SARS-CoV-2：拟议的靶标和已上市药物。
Future Med Chem. 2020 Sep;12(17):1579-1601. doi: 10.4155/fmc-2020-0147. Epub 2020 Jun 22.
本文引用的文献
1
Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases.新型冠状病毒肺炎及相关人类冠状病毒疾病治疗药物和疫苗的研发
ACS Cent Sci. 2020 Mar 25;6(3):315-331. doi: 10.1021/acscentsci.0c00272. Epub 2020 Mar 12.
2
Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2.基于网络的2019新型冠状病毒（2019-nCoV/SARS-CoV-2）药物重新利用研究
Cell Discov. 2020 Mar 16;6:14. doi: 10.1038/s41421-020-0153-3. eCollection 2020.
3
Clinical Features of 69 Cases With Coronavirus Disease 2019 in Wuhan, China.中国武汉 69 例 2019 年冠状病毒病患者的临床特征。
Clin Infect Dis. 2020 Jul 28;71(15):769-777. doi: 10.1093/cid/ciaa272.
4
The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status.2019 冠状病毒病（COVID-19）疫情的起源、传播和临床治疗——现状更新。
Mil Med Res. 2020 Mar 13;7(1):11. doi: 10.1186/s40779-020-00240-0.
5
Discovering drugs to treat coronavirus disease 2019 (COVID-19).发现治疗2019冠状病毒病（COVID-19）的药物。
Drug Discov Ther. 2020;14(1):58-60. doi: 10.5582/ddt.2020.01012.
6
Chloroquine and hydroxychloroquine as available weapons to fight COVID-19.氯喹和羟氯喹作为对抗新型冠状病毒肺炎的现有武器。
Int J Antimicrob Agents. 2020 Apr;55(4):105932. doi: 10.1016/j.ijantimicag.2020.105932. Epub 2020 Mar 4.
7
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.严重急性呼吸综合征冠状病毒 2 型（SARS-CoV-2）进入细胞依赖于 ACE2 和 TMPRSS2，可被一种临床验证的蛋白酶抑制剂所阻断。
Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.
8
Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics.血管紧张素受体阻滞剂可作为治疗 SARS-CoV-2 的候选药物。
Drug Dev Res. 2020 Aug;81(5):537-540. doi: 10.1002/ddr.21656. Epub 2020 Mar 4.
9
Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review.2019新型冠状病毒（2019-nCoV）的潜在快速诊断方法、疫苗及治疗手段：一项系统综述
J Clin Med. 2020 Feb 26;9(3):623. doi: 10.3390/jcm9030623.
10
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
Zotero 插件